Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.
New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback